Aortoiliac embolism causing acute limb ischaemia requires prompt anticoagulation. When confirmed or suspected heparin-induced thrombocytopenia (HIT) is present, anticoagulant selection follows a specific protocol distinct from standard management.
Acute limb ischaemia in a patient with confirmed or suspected heparin-induced thrombocytopenia. The presence of HIT — confirmed or suspected — determines the anticoagulation strategy used in this setting.
Management centres on non-heparin anticoagulants. The specific agents indicated and the complete clinical regimen are available in the full structured protocol.
DOI: 10.1016/j.ejvs.2019.09.006
In patients with confirmed or suspected heparin induced thrombocytopenia, non-heparin anticoagulants such as lepirudin, argatroban, or danaparoid are options.
View source ↗